Old Mission Capital’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,366
Closed -$1.01M 1253
2026
Q1
$1.01M Buy
+54,366
New +$1.03M 0.02% 435
2025
Q4
Sell
-55,560
Closed -$983K 1192
2025
Q3
$983K Buy
+55,560
New +$1.15M 0.02% 438
2025
Q2
Sell
-9,903
Closed -$273K 1232
2025
Q1
$273K Buy
9,903
+6,947
+235% +$267K ﹤0.01% 798
2024
Q4
$155K Buy
+2,956
New +$185K ﹤0.01% 862
2024
Q1
Sell
-2,177
Closed -$514K 1517
2023
Q4
$514K Buy
+2,177
New +$432K 0.01% 765

Other funds holding MRNY

Old Mission Capital's MRNY Position: Q2 2026 in Review

Old Mission Capital sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026, closing a stake of 54,366 shares — an estimated $1.01M sold.

Old Mission Capital first reported a position in MRNY in Q4 2023 and held it in 5 quarters. The position peaked at $1.01M in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Old Mission Capital reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q2 2026 after selling out during the quarter.
  • Old Mission Capital sold 54,366 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $1.01M.
  • Old Mission Capital first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2023 and held it in 5 quarters.
  • Old Mission Capital's YieldMax MRNA Option Income Strategy ETF position peaked at $1.01M in Q1 2026.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Old Mission Capital's 13F filing for Q2 2026, filed 14 Aug 2026.